文摘

酶联immunospot试验测试的价值在结核性胸膜炎的诊断和评估疗效

作者(年代):最起码吴克良、Fu Xiuhua张Guizhi,李国华,顾,高Junzhen

摘要目的:探讨酶联immunospot试验测试的价值有关酶联免疫斑点)((结核感染t细胞斑点)结核性胸膜炎的诊断和治疗效果。方法:收集93例ofAffiliated InnerMongoliaMedical大学医院胸腔积液患者。辅助治疗的外周血和胸腔积液非出血性渗出性胸腔积液被T-SPOT测试。结核病治疗之前。患者的外周血临床诊断为结核性胸膜炎被T-SPOT测试。结核病又3个月后常规抗结核。结果:有辅助治疗63例93年诊断为结核性胸膜炎胸腔积液。其中,积极T-SPOT率。结核病测试在外周血和胸腔积液分别为90.48%(57/63)和100% (63/63)。有30例被诊断为非结核性胸膜炎。其中,负T-SPOT率。结核病测试在外周血和胸腔积液是83.33%(25/30)和70% (21/30)。在我们的研究中,(特异性)和阴性预测值T-SPOT的阳性预测值。结核病测试周边血液中80.65%(25/31)和91.94% (57/62)。消极的预测价值和T-SPOT的阳性预测值。结核病测试在胸腔积液是100%(21/21)和87.5% (63/72)。 The average numbers of spot forming cells(SFCs) in Pleural effusion were 4.69 times that in peripheral blood.The numbers of SFCs in peripheral blood were obviously decreased or loss after 3 months anti tuberculosis therapy. Conclusion: T-SPOT TB is a sensitive and specific test in the diagnosis of tuberculous pleurisy, especialy in pleural effusion. T-SPOT TB can be used as evaluation index of tuberculosis treatment.